These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3014837)

  • 21. Liposomal dosage form development--some practical considerations.
    Rao LS
    J Parenter Sci Technol; 1983; 37(3):72-5. PubMed ID: 6308198
    [No Abstract]   [Full Text] [Related]  

  • 22. [Methylglucamine antimoniate and sodium stibogluconate in the treatment of leishmaniasis. Study of 16 cases].
    Bourée P; Anciaux ML; Taugourdeau P
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):607-10. PubMed ID: 3003657
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of experimental cutaneous leishmaniasis by liposome-entrapped Pentostam.
    New RR; Chance ML
    Acta Trop; 1980 Sep; 37(3):253-6. PubMed ID: 6106363
    [No Abstract]   [Full Text] [Related]  

  • 24. Anti leishmanial therapy--the changing scene.
    Bichile LS
    J Assoc Physicians India; 1994 Sep; 42(9):682-3. PubMed ID: 7883657
    [No Abstract]   [Full Text] [Related]  

  • 25. Treatment of post-kala-azar dermal leishmaniasis with sodium stibogluconate.
    Thakur CP; Kumar K; Sinha PK; Mishra BN; Pandey AK
    Br Med J (Clin Res Ed); 1987 Oct; 295(6603):886-7. PubMed ID: 2823955
    [No Abstract]   [Full Text] [Related]  

  • 26. Requirement for T cells and effect of lymphokines in successful chemotherapy for an intracellular infection. Experimental visceral leishmaniasis.
    Murray HW; Oca MJ; Granger AM; Schreiber RD
    J Clin Invest; 1989 Apr; 83(4):1253-7. PubMed ID: 2539396
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Electron microscopy of Leishmania donovani in splenic aspirates from patients with visceral leishmaniasis during treatment with sodium stibogluconate.
    Chulay JD; Fawcett DW; Chunge CN
    Ann Trop Med Parasitol; 1985 Aug; 79(4):417-29. PubMed ID: 3000304
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of cutaneous leishmaniasis with an intralesional antimonial drug (Pentostam).
    Kellum RE
    J Am Acad Dermatol; 1986 Oct; 15(4 Pt 1):620-2. PubMed ID: 3021826
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of visceral leishmaniasis using sodium stibogluconate in a dose of 15 mg antimony/kg body weight twice daily for 30 days: a preliminary report.
    Chunge CN; Gachihi G; Mugambi M; Chulay JD; Spencer HC
    East Afr Med J; 1984 Jul; 61(7):570-4. PubMed ID: 6100588
    [No Abstract]   [Full Text] [Related]  

  • 30. Treatment of visceral leishmaniasis in Kenya by aminosidine alone or combined with sodium stibogluconate.
    Chunge CN; Owate J; Pamba HO; Donno L
    Trans R Soc Trop Med Hyg; 1990; 84(2):221-5. PubMed ID: 2167522
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Evaluation of the effectiveness and toxicity of pentostam and glucantime in the treatment of cutaneous leishmaniasis].
    Sáenz RE; Paz HM; Johnson CM; Narvaez E; de Vásquez AM
    Rev Med Panama; 1987 Sep; 12(3):148-57. PubMed ID: 2827242
    [No Abstract]   [Full Text] [Related]  

  • 32. Recommendations for treating leishmaniasis with sodium stibogluconate (Pentostam) and review of pertinent clinical studies.
    Herwaldt BL; Berman JD
    Am J Trop Med Hyg; 1992 Mar; 46(3):296-306. PubMed ID: 1313656
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of cutaneous leishmaniasis with antimony sodium gluconate.
    Koerber WA; Koehn MC; Jacobs PH; Russel BJ
    Arch Dermatol; 1978 Aug; 114(8):1226. PubMed ID: 209753
    [No Abstract]   [Full Text] [Related]  

  • 34. Leishmaniasis recidivans treated with sodium stibogluconate.
    Schewach-Millet M; Fisher BK; Semah D
    Cutis; 1981 Jul; 28(1):67-8, 77, 84 passim. PubMed ID: 6266776
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A successful treatment of a Kenyan case of unresponsive cutaneous leishmaniasis with a combination of pentostam and oral allopurinol: case report.
    Kirigi G; Mbuchi MW; Mbui JK; Rashid JR; Kinoti DM; Njoroge SN; Basiye F; Magiri C; Wasunna MK
    East Afr Med J; 2010 Dec; 87(12):521-4. PubMed ID: 23457863
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ECG changes in prolonged treatment of kala-azar with antimony compounds.
    Pandey AK; Kumar M; Thakur CP
    J Assoc Physicians India; 1988 Jun; 36(6):398-9. PubMed ID: 2846508
    [No Abstract]   [Full Text] [Related]  

  • 37. Treatment of leishmaniasis with sodium antimony gluconate: transient ECG findings.
    Kaplan RJ; Wilkin JK; Hartman DL
    South Med J; 1978 Apr; 71(4):469-70. PubMed ID: 205001
    [No Abstract]   [Full Text] [Related]  

  • 38. [Treatment of visceral leishmaniasis in children].
    Minodier P; Noël G; Blanc P; Uters M; Retornaz K; Garnier JM
    Med Trop (Mars); 2007 Feb; 67(1):73-8. PubMed ID: 17506279
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of pentavalent antimony (Pentostam) in hamsters.
    Berman JD; Gallalee JF; Gallalee JV
    Am J Trop Med Hyg; 1988 Jul; 39(1):41-5. PubMed ID: 2840834
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rationalisation of regimens of treatment of kala-azar with sodium stibogluconate in India: a randomised study.
    Thakur CP; Kumar M; Kumar P; Mishra BN; Pandey AK
    Br Med J (Clin Res Ed); 1988 Jun; 296(6636):1557-61. PubMed ID: 2840172
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.